Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
1.570
-0.010 (-0.63%)
At close: Apr 28, 2026, 4:00 PM EDT
1.579
+0.009 (0.59%)
After-hours: Apr 28, 2026, 4:18 PM EDT
Aldeyra Therapeutics Employees
Aldeyra Therapeutics had 8 employees as of December 31, 2025. The number of employees decreased by 1 or -11.11% compared to the previous year.
Employees
8
Change (1Y)
-1
Growth (1Y)
-11.11%
Revenue / Employee
n/a
Profits / Employee
-$4,230,833
Market Cap
94.49M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Inovio Pharmaceuticals | 112 |
| Fractyl Health | 100 |
| PolyPid | 75 |
| Rani Therapeutics Holdings | 71 |
| eXoZymes | 32 |
| Q32 Bio | 24 |
| NeurAxis | 24 |
| ProMIS Neurosciences | 11 |
ALDX News
- 5 days ago - ALDX INVESTOR REMINDER: Aldeyra Therapeutics, Inc. Investors Have Until May 29, 2026 To Seek Lead Plaintiff Role - Business Wire
- 8 days ago - ADLX Stockholders Have Rights – If You Lost Money Investing in Aldeyra Therapeutics, Inc. Contact Robbins LLP for Information About Recovering Your Losses - GlobeNewsWire
- 12 days ago - Bragar Eagel & Squire, P.C. Encourages Aldeyra Therapeutics, Inc. Investors to Contact the Firm Regarding Their Rights - GlobeNewsWire
- 21 days ago - Shareholders who lost money in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) Should Contact Wolf Haldenstein Immediately - PRNewsWire
- 4 weeks ago - $ALDX Lawsuit: Aldeyra Therapeutics, Inc. Sued for Securities Fraud; Investors Should Contact Block & Leviton to Possibly Recover Losses - GlobeNewsWire
- 5 weeks ago - What's Going On With Aldeyra Therapeutics Stock On Thursday? - Benzinga
- 6 weeks ago - Aldeyra Therapeutics Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - Newsfile Corp
- 6 weeks ago - US FDA declines to approve Aldeyra's drug for eye disorder - Reuters